Aptamers Market

Global Aptamers Market Report: By Type (Nucleic Acid, Peptide), By Application (Diagnostics, Therapeutics, Research & Developments, Others), and Region (North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa) Global Industry Analysis, Size, Share, Growth, Trends, Regional Analysis, Competitor Analysis and Forecast 2023-2031.

Biotechnology | January 2024 | Report ID: EMR00452 | Pages: 301

Global Aptamers market is predicted to reach approximately USD 9.52 billion by 2031, at a CAGR of 17.44% from 2022 to 2031.

Short single-stranded DNA or RNA molecules known as aptamers are chosen for their high affinity and specificity in binding to particular target molecules. Because of this special quality, aptamers are now seen as viable substitutes for antibodies in a range of biological applications. Innovations in aptamer selection technologies, like systematic evolution of ligands by exponential enrichment (SELEX), which improve aptamer binding efficiency and specificity, are driving the market. Because they provide quick and affordable solutions, diagnostic applications—such as biomarker detection and point-of-care testing—have emerged as major market drivers. Additionally, the use of aptamers in drug development has been driven by the growing need for targeted therapies and personalised medicine, which has resulted in an increase in research and development activities

 

 

Global Aptamers report scope and segmentation.

Report Attribute

Details

Estimated Market Value (2022)

USD 2.24 billion

Projected Market Value (2031)

USD 9.52 billion

Base Year

2022

Forecast Years

2023 – 2031

Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Based on By Type, Application & Region.

Segments Covered

By Type, Application & By Region.

Forecast Units

Value (USD Billion or Million), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2023 to 2031.

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others.

Report Coverage

Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis.

Delivery Format

Delivered as an attached PDF and Excel through email, according to the purchase option.

 

Global Aptamers dynamics

The growing need for precise and sensitive molecular recognition instruments in therapeutics and diagnostics is one of the main factors. Because of their exceptional capacity to attach only to target molecules, aptamers are more advantageous than conventional antibodies in that they are simpler to synthesis, less immunogenic, and less expensive. The market is growing as a result of aptamers' growing uses in personalised medicine, infectious disease detection, and cancer diagnostics.

Research and development endeavours are crucial in determining the dynamics of the market, as ongoing advancements in aptamer selection technologies and optimisation procedures improve their binding characteristics and expand their potential applications. Furthermore, investments in the development of aptamer-based drugs are being driven by the increasing emphasis on targeted therapies and precision medicine, which is further propelling the market expansion. Industry participants and academic institutions frequently collaborate strategically, which promotes knowledge sharing and the creation of innovative aptamer-based solutions.

 

Global Aptamers drivers

  • Growing Demand for Precision Medicine  

The market for aptamers is being driven in part by the growing need for precision medicine. Aptamers, with their high specificity and affinity for target molecules, are essential to this paradigm shift towards personalised therapies. Aptamers present themselves as flexible tools for targeted drug delivery and the identification of particular biomarkers linked to a variety of diseases, as the healthcare industry increasingly focuses on customising treatments to individual patient profiles. The market for aptamers is growing as a result of this demand, which is encouraging intensive research and development.

  • Advancements in Diagnostic Technologies  

The market for aptamers is also significantly fuelled by the ongoing developments in diagnostic technologies. Because aptamers can bind selectively to target molecules, they are excellent choices for use in diagnostic applications. Aptamers offer quick and accurate detection techniques in areas like infectious disease and cancer diagnosis. Aptamers are becoming more and more popular due to the growing trend of point-of-care testing and the need for more accurate and efficient diagnostic tools. This driver is pushing companies to invest in developing novel aptamer-based diagnostic assays, contributing to the overall market growth.

 

Restraints:

  • Regulatory Challenges  

One significant barrier to the aptamers market is the complexity of regulations. The distinct characteristics of aptamer-based products make it difficult to establish standardised regulatory pathways. The marketability of aptamer-based diagnostics and treatments may be hampered by protracted approval procedures brought on by unclear regulatory frameworks. Clear guidelines for the development and commercialization of aptamer products must be established by regulatory bodies in cooperation with industry stakeholders in order to overcome these regulatory obstacles.

  • Limited Awareness and Understanding  

Aptamers have potential, but they are constrained by end users' and healthcare professionals' lack of knowledge and comprehension. Adoption rates are slower because aptamers' special qualities and uses are not well understood. To get past this barrier and make sure that the research and healthcare communities are aware of the advantages of aptamers, it is imperative to raise awareness through educational programmes and focused marketing campaigns.

 

Opportunities:

  • Increased Focus on Point-of-Care Testing  

For the aptamers market, the increasing focus on point-of-care testing offers a significant opportunity. Aptamers are a good fit for point-of-care diagnostic applications due to their quick and focused binding abilities. Aptamer-based point-of-care assays have an advantageous environment for development and commercialization due to the global shift towards decentralised healthcare and the need for prompt and accurate diagnostics, particularly in settings with limited resources. Businesses that put money into creating portable, easy-to-use aptamer-based diagnostic instruments will profit from the growing market for point-of-care testing.

 

Segment Overview

  • By type

Nucleic Acid Aptamers are oligonucleotide-based molecules, either DNA or RNA, selected for their ability to bind specifically to target molecules. These aptamers are synthesized through systematic evolution of ligands by exponential enrichment (SELEX) processes, enabling the identification of high-affinity sequences for various applications. Peptide Aptamers, on the other hand, are short peptides chosen for their target-binding capabilities. These segments cater to the diverse needs of the market, providing options for specific applications and target molecules.

  • By Application  

Aptamers are widely used in a critical market segment: diagnostics. In diagnostic assays, aptamers function as extremely specific recognition elements that make it easier to identify biomarkers linked to a range of illnesses. Aptamers are essential to the therapeutics segment's drug development process. They present a viable option for the development of targeted therapies with fewer side effects because they can be made to specifically target proteins implicated in certain diseases. The use of aptamers in diverse laboratory applications, such as target validation, biomarker discovery, and assay development, is covered under the Research & Development section. This segment underscores the versatility of aptamers in advancing scientific research.

 

Global Aptamers Overview by Region

North America, led by the US, has a sizable portion because of its thriving biotechnology and pharmaceutical sectors. The area gains from significant R&D expenditures that support technical developments in aptamer selection procedures and applications. Additionally, the widespread use of aptamers in diagnostics and therapeutics is facilitated by the rising incidence of chronic illnesses and the growing need for personalised medicine.

Europe follows closely, with countries like Germany, the United Kingdom, and France playing pivotal roles in market expansion. The European market benefits from a strong emphasis on scientific research, coupled with favourable government initiatives promoting biotechnological innovations. The increasing awareness of aptamer technologies and their potential applications in precision medicine further fuels market growth in this region.

 

 

Global Aptamers market competitive landscape

Major companies such as Aptamer Sciences Inc., Base Pair Biotechnologies Inc., and NOXXON Pharma AG are at the forefront of technological innovation, driving advancements in aptamer research, development, and commercialization. These industry leaders leverage strategic collaborations, partnerships, and acquisitions to expand their product portfolios, enhance research capabilities, and solidify their market presence.

Smaller competitors and newly established biotechnology companies also influence the competitive dynamics by focusing on particular aptamer types or niche applications. New start-ups investigating cutting-edge technologies for aptamer selection and application development are constantly entering the market. The competitive landscape is diverse, which encourages innovation and speeds up the development of aptamer-based solutions in a range of industries.

The competitive landscape is further characterised by partnerships between academic institutions and industry players, which promote knowledge sharing and the advancement of cutting-edge aptamer technologies. Academic establishments are essential for developing our knowledge of aptamer biology and broadening its range of applications. By encouraging a collaborative ecosystem that speeds up R&D cycles, this collaboration-driven strategy increases the market's overall competitiveness.

 

Global Aptamers Recent Developments

  • Dec 2023, Zentek Ltd. a company specializing in the development and commercialization of intellectual property technology, is pleased to introduce Triera Biosciences Ltd. (Triera) as its fully owned subsidiary dedicated to the aptamer platform technology. Zentek disclosed that Triera has secured exclusive global licensing rights for all aptamer-based technology resulting from the collaboration with McMaster University.

 

Scope of global Aptamers report

Global Aptamers report segmentation

ATTRIBUTE

DETAILS

By Type

  • Nucleic Acid Aptamer
  • Peptide Aptamer  

By Application

  • Diagnostics
  • Therapeutics
  • Research & Development
  • Others

By Geography

  • North America (USA, and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Customization Scope

  • Available upon request

Pricing

  • Available upon request

 

Objectives of the Study

The objectives of the study are summarized in 5 stages. They are as mentioned below:

  • Global Aptamers size and forecast: To identify and estimate the market size for global Aptamers market segmented by Type, Application and by region. Also, to understand the consumption/ demand created by consumers between 2023 and 2031.
  • Market Landscape and Trends: To identify and infer the drivers, restraints, opportunities, and challenges for global Aptamers
  • Market Influencing Factors: To find out the factors which are affecting the market of global Aptamers among consumers.
  • Company Profiling:  To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company's past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies

Research Methodology

Our research methodology has always been the key differentiating reason which sets us apart in comparison from the competing organizations in the industry. Our organization believes in consistency along with quality and establishing a new level with every new report we generate; our methods are acclaimed and the data/information inside the report is coveted. Our research methodology involves a combination of primary and secondary research methods. Data procurement is one of the most extensive stages in our research process. Our organization helps in assisting the clients to find the opportunities by examining the market across the globe coupled with providing economic statistics for each and every region.  The reports generated and published are based on primary & secondary research. In secondary research, we gather data for global Market through white papers, case studies, blogs, reference customers, news, articles, press releases, white papers, and research studies. We also have our paid data applications which includes hoovers, Bloomberg business week, Avention, and others.

Data Collection

Data collection is the process of gathering, measuring, and analyzing accurate and relevant data from a variety of sources to analyze market and forecast trends. Raw market data is obtained on a broad front. Data is continuously extracted and filtered to ensure only validated and authenticated sources are considered. Data is mined from a varied host of sources including secondary and primary sources.

Primary Research

After the secondary research process, we initiate the primary research phase in which we interact with companies operating within the market space. We interact with related industries to understand the factors that can drive or hamper a market. Exhaustive primary interviews are conducted. Various sources from both the supply and demand sides are interviewed to obtain qualitative and quantitative information for a report which includes suppliers, product providers, domain experts, CEOs, vice presidents, marketing & sales directors, Type & innovation directors, and related key executives from various key companies to ensure a holistic and unbiased picture of the market. 

Secondary Research

A secondary research process is conducted to identify and collect information useful for the extensive, technical, market-oriented, and comprehensive study of the market. Secondary sources include published market studies, competitive information, white papers, analyst reports, government agencies, industry and trade associations, media sources, chambers of commerce, newsletters, trade publications, magazines, Bloomberg BusinessWeek, Factiva, D&B, annual reports, company house documents, investor presentations, articles, journals, blogs, and SEC filings of companies, newspapers, and so on. We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

Top-Down Approach & Bottom-Up Approach

In the top – down approach, the Global Batteries for Solar Energy Storage Market was further divided into various segments on the basis of the percentage share of each segment. This approach helped in arriving at the market size of each segment globally. The segments market size was further broken down in the regional market size of each segment and sub-segments. The sub-segments were further broken down to country level market. The market size arrived using this approach was then crosschecked with the market size arrived by using bottom-up approach.

In the bottom-up approach, we arrived at the country market size by identifying the revenues and market shares of the key market players. The country market sizes then were added up to arrive at regional market size of the decorated apparel, which eventually added up to arrive at global market size.

This is one of the most reliable methods as the information is directly obtained from the key players in the market and is based on the primary interviews from the key opinion leaders associated with the firms considered in the research. Furthermore, the data obtained from the company sources and the primary respondents was validated through secondary sources including government publications and Bloomberg.

Market Analysis & size Estimation

Post the data mining stage, we gather our findings and analyze them, filtering out relevant insights. These are evaluated across research teams and industry experts. All this data is collected and evaluated by our analysts. The key players in the industry or markets are identified through extensive primary and secondary research. All percentage share splits, and breakdowns have been determined using secondary sources and verified through primary sources. The market size, in terms of value and volume, is determined through primary and secondary research processes, and forecasting models including the time series model, econometric model, judgmental forecasting model, the Delphi method, among Flywheel Energy Storage. Gathered information for market analysis, competitive landscape, growth trends, product development, and pricing trends is fed into the model and analyzed simultaneously.

Quality Checking & Final Review

The analysis done by the research team is further reviewed to check for the accuracy of the data provided to ensure the clients’ requirements. This approach provides essential checks and balances which facilitate the production of quality data. This Type of revision was done in two phases for the authenticity of the data and negligible errors in the report. After quality checking, the report is reviewed to look after the presentation, Type and to recheck if all the requirements of the clients were addressed.

Frequently Asked Questions

Global Aptamers forecast period is 2023 - 2031.
According to global Aptamers research, the market is expected to grow at a CAGR of ~ 17.44% over the next eight years.
The possible segments in global Aptamers are based on by Type, Application, & by region.
The expected market size for Global Aptamers is USD 2.24 billion in 2022.
The major players in the market are TriLink Biotechnologies, Noxxon Pharma, SomaLogic, Aptamer Group, Base Pair Biotechnologies, Vivonics Inc., Aptadel Therapeutics, Aptagen, LLC and Altermune LLC